The approval follows the 2021 approval of a 42 mg formulation given every 6 months.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/lower-dose-leuprolide-agent-earns-fda-nod-advanced-prostate-2025a1000n6m?src=rss
Author :
Publish date : 2025-09-02 21:18:00
Copyright for syndicated content belongs to the linked Source.